Chemist Warehouse’s decision to change suppliers means the Amcal-owner is set to lose its biggest retail customers.
Pharmacy chains: To float or not to float?
Legal experts suggest class actions are on the rise in Australia, should retailers be worried?
The pharmacy sector is being reshaped in the face of tougher trading conditions, higher costs, lower PBS payments and a powerful industry disrupter.
Amcal owner appoints ASX listed exec as its new CFO.
For CEOs, ignorance is not a defence and a lack of recall on crucial operational issues is not an escape hatch.
A sneak peek at what’s featured in this week’s issue of Inside Retail Weekly.
Inside Sigma Pharmaceuticals’ efforts to build a direct market presence in China for its Amcal brand.
Pharmacy group ventures into China with e-commerce store.